Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-03-06 @ 8:46 AM
Study NCT ID:
NCT02879760
Status:
COMPLETED
Last Update Posted:
2020-10-06
First Post:
2016-08-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients
Sponsor:
Turnstone Biologics, Corp.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-08
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-15
First Submit QC Date:
None
Study First Post Date:
2016-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-05
Last Update Post Date:
2020-10-06
Last Update Post Date Type:
ACTUAL